Pet Joint Health Supplements Market Forecasts to 2034 - Global Analysis By Ingredient Type, Pet Type, Product Format, Sales Channel, Joint Health Indication, Pet Life Stage, and By Geography

According to Stratistics MRC, the Global Pet Joint Health Supplements Market is accounted for $0.6 billion in 2026 and is expected to reach $1.0 billion by 2034 growing at a CAGR of 6.6% during the forecast period. The market covers non-prescription nutritional products intended to support joint function and mobility in pets, including glucosamine, chondroitin, omega-3 oils, collagen, and MSM. It is used to complement veterinary care for stiffness, activity-related strain and age-associated mobility decline. Growth reflects greater awareness of osteoarthritis and senior-pet needs and preventive nutrition. Demand will depend on measurable performance, cost-effectiveness, user awareness and access to suitable solutions.

Market Dynamics:

Driver:

Greater focus on mobility, osteoarthritis and healthy aging

Greater owner focus on mobility, osteoarthritis and healthy aging is driving demand for pet joint health supplements. Senior pets and active dogs are increasingly managed with glucosamine, chondroitin, omega-3 oils, collagen and MSM as part of preventive or supportive care. Veterinary recommendations, breed awareness and premium nutrition trends support repeat purchase. As owners seek to preserve comfort and activity, demand is likely to remain steady across soft chews, powders and capsules, particularly where products are positioned for long-term daily use.

Restraint:

Uneven clinical evidence and supplement quality

Uneven clinical evidence and variable supplement quality constrain confidence in pet joint health supplements. Ingredient levels, sourcing, stability and bioavailability can differ widely, and not all products are supported by robust trials or clear label claims. Veterinarians may hesitate to recommend products with limited evidence, while owners struggle to compare formulations. Regulatory variation adds further complexity. Quality assurance, transparent labeling and condition-specific evidence are essential to differentiate credible products and support sustained veterinary endorsement.

Opportunity:

Evidence-led formulations and integrated mobility programs

Evidence-led formulations and integrated mobility programs offer a clear opportunity in pet joint health supplements. Products supported by clinical data, clear dosing and transparent sourcing can earn veterinary trust and command premium positioning. Combining supplements with weight management, exercise guidance and rehabilitation referrals can improve outcomes and retention. Practitioner partnerships, online education and follow-up services can broaden access beyond major cities. Providers that coordinate with clinics, retailers and service organizations can build credible, long-term mobility care pathways.

Threat:

Unsupported claims and competition from established treatments

Unsupported claims and competition from established treatments threaten the pet joint health supplement market. Overstated benefits or poor-quality products can damage owner and veterinarian trust, while lower-priced substitutes pressure margins. Prescription analgesics, therapeutic diets and rehabilitation services may compete for the same care occasions. Regulatory scrutiny of claims and inconsistent online information add risk. Companies need credible evidence, traceable sourcing, responsible marketing and clear positioning to protect reputation and sustain veterinary recommendation in a crowded category over time.

Covid-19 Impact:

The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.

The Glucosamine and Chondroitin segment is expected to be the largest during the forecast period

The Glucosamine and Chondroitin segment is expected to account for a leading share of the pet joint health supplements market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal ingredient type applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.

The Other Companion Animals segment is expected to have the highest CAGR during the forecast period

The Other Companion Animals segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.

Region with largest share:

North America is expected to account for a leading share of the pet joint health supplements market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.

Region with highest CAGR:

Asia Pacific is expected to exhibit strong growth in the pet joint health supplements market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.

Key players in the market

Some of the key players in the Global Pet Joint Health Supplements Market include Nutramax Laboratories, VetriScience Laboratories, Zesty Paws, PetHonesty, NaturVet, VetPlus Ltd., GlycoFlex (FoodScience LLC), Animal Essentials, PetNC Natural Care, Native Pet, PawCo Foods, Dasuquin (Nutramax), Cosequin (Nutramax), Only Natural Pet, Nupro Supplements, Purina Pro Plan Veterinary Supplements.

Key Developments:

In July 2026, Prefera Pet Food UK launched a pump-format supplement range targeting joint mobility, skin and coat, digestion, calming and other everyday health needs in dogs and cats.

In May 2026, Gallant reported positive pilot data for a canine osteoarthritis cell-therapy program and FDA eligibility for an expanded conditional-approval pathway, supporting development of off-the-shelf veterinary regenerative medicine.

In April 2026, Hill's Pet Nutrition announced Prescription Diet Metabolic + j/d for cats, combining weight-management and joint-support nutrition in one veterinarian-recommended formula.

Ingredient Types Covered:

• Glucosamine and Chondroitin
• Omega-3 Fatty Acids
• Collagen and UC-II
• MSM and Green-Lipped Mussel
• Botanical Joint Support

Pet Types Covered:

• Dogs
• Cats
• Other Companion Animals

Product Formats Covered:

• Soft Chews
• Powders
• Liquids
• Capsules and Tablets

Sales Channels Covered:

• Veterinary Clinics
• Specialty Pet Stores
• Online Retail
• General Retail

Joint Health Indications Covered:

• Osteoarthritis and Degenerative Joint Disease
• Exercise and Activity-Related Support
• Post-Injury and Post-Surgical Support

Pet Life Stages Covered:

• Adult Pets
• Mature Pets
• Senior Pets

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances